Why the study?
Does nesiritide improve hemodynamics and symptoms compared to nitroglycerin or dobutamine in patients with acutely decompensated heart failure?
Population
Patients with acutely decompensated heart failure
Comparison
Nesiritide vs Intravenous nitroglycerin and dobutamine
Design
Review
Authors
Loading...
May support nesiritide over nitroglycerin in acute HF; leaves open need for randomized confirmation.
Does nesiritide improve hemodynamics and symptoms compared to nitroglycerin or dobutamine in patients with acutely decompensated heart failure?
Nesiritide is an effective alternative for managing acutely decompensated heart failure, particularly for patients unresponsive to other therapies or at high risk of arrhythmias.
Vichiendilokkul et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: